Skip to content
lifestyle.xbode.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sanofi Winthrop Industrie
Press release: Availability of the Q1 2026 aide-mémoire
March 24, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
March 24, 2026
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
March 18, 2026
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
March 5, 2026
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
March 4, 2026
Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
March 2, 2026
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi
February 12, 2026
Press Release: Sanofi completes the acquisition of Dynavax
February 11, 2026
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
February 9, 2026
←
Previous Page
1
2
3
4